Attached files
| file | filename |
|---|---|
| EX-99.1 - EX-99.1 - Truven Health Analytics Inc. | a14-23774_4ex99d1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): November 6, 2014
|
Truven Holding Corp. |
|
Truven Health Analytics Inc. |
|
(Exact name of registrant parent guarantor as |
|
(Exact name of registrant issuer as |
|
Delaware |
|
45-5164353 |
|
Delaware |
|
06-1467923 |
|
(State or other |
|
(I.R.S. Employer |
|
(State or other |
|
(I.R.S. Employer |
777 E. Eisenhower Parkway
Ann Arbor, Michigan 48108
(734) 913-3000
(Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant’s Principal Executive Offices)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
o |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
|
|
o |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17CFR 240.14a-12) |
|
|
|
|
o |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
|
|
o |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 7.01. Regulation FD Disclosure.
The Company is updating certain information about its business and recently concluded and proposed acquisitions that was not previously disclosed. This information is included herewith as Exhibit 99.1 and incorporated herein by reference.
The information disclosed under this Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and shall not be deemed incorporated by reference into any filing made under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as expressly set forth by specific reference in such filing. The furnishing of this information pursuant to Item 7.01 shall not be deemed an admission by the Company as to the materiality of such information.
Item 9.01. Financial Statements and Exhibits.
|
Exhibit No. |
|
Description |
|
|
|
|
|
99.1 |
|
Information provided to investors. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
TRUVEN HOLDING CORP. |
|
TRUVEN HEALTH ANALYTICS INC. | ||
|
(Registrant) |
|
(Registrant) | ||
|
|
|
| ||
|
By: |
/s/ ANDRA K. HELLER |
|
By: |
/s/ ANDRA K. HELLER |
|
Andra K. Heller, General Counsel and Secretary |
|
Andra K. Heller, General Counsel and Secretary | ||
|
Date: November 6, 2014 |
|
Date: November 6, 2014 | ||
EXHIBIT INDEX
|
Exhibit No. |
|
Description |
|
99.1 |
|
Information provided to investors. |